Log in
Enquire now
‌

US Patent 8445451 Macrolides and uses of macrolides

Patent 8445451 was granted and assigned to Basilea Pharmaceutica on May, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Basilea Pharmaceutica
Basilea Pharmaceutica
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
84454510
Patent Inventor Names
Johannes Laurenz Kellenberger0
Jürg Dreier0
Stefan Bernhard Reinelt0
Date of Patent
May 21, 2013
0
Patent Application Number
128659480
Date Filed
February 9, 2009
0
Patent Primary Examiner
‌
Elli Peselev
0
Patent abstract

Macrolides of Formula (I) or (I-A): and wherein the residues R1, R2, R3, R4, R12, R13 and R14 have certain meanings defined in this application are useful for treating or preventing inflammatory or allergic diseases or, cancer in animals and humans.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8445451 Macrolides and uses of macrolides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us